In "the Dark Ages of Health" the point was made, that we currently lack diagnostic tests and treatment in order to handle all kind of pathogens, that use human bodies as their home. The question was raised, how long it will take, in order to reach these diagnostic tests and treatments. At least for the former problem we are further ahead, than most people think. There is a company called Nanosphere, which developed some very neat microbiology tests. What is really wonderful about these tests, is their high grade of sensitivity, specificity, speed (results within 3 hours), price (the test costs less than $100) and the best part, the respiratory virus test was FDA approved in 2011 and their bacteria test was approved by the FDA this year. Here is a small overview of what they can test for: http://www.nanosphere.us/product/respiratory-virus-plus n > 1000 Virus Sens.(%) Spec.(%) Influenza Ab 100 100 Influenza A - H3 100 100 Influenza A - H1 100 99.9 Influenza A - 2009 H1N1 99.5 100 Influenza B 100 100 Their bacteria test seems to come close to what KDM does with R.E.D laboratories, the big difference is, that Nanosphere is FDA approved,much cheaper and includes more bacteria. http://www.nanosphere.us/product/gram-positive-blood-cultures (FDA approved) http://www.nanosphere.us/product/gram-negative-blood-culture (for research only) My bigger hope however, is their Respiratory Virus XP test. It still is research based but includes testing for: Influenza A Flu A - H1 Flu A - H3 Flu A - 2009 H1N1 H275Y (Oseltamivir Resistance) Influenza B RSV A RSV B Parainfluenza 1 Parainfluenza 2 Parainfluenza 3 Parainfluenza 4 Human Metapneumovirus Adenovirus (Species A - F) Rhinovirus (Species A and B)/Enterovirus (Species A - D) Especially the last (Adeno/Rhino/Entero) caught my attention because I would be very interested to test for them. In addition to this, I hope that they develop tests for EBV, HHV-6, HHV-7 etc.. In the end, diagnostics will become more sensitive, more specific, faster, cheaper and easier. Therefore they could open a path towards determining what role pathogens really play for humans and diseases (including CFS).